Do larger periprocedural fluid volumes reduce the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis?

Pancreas

Volumn 43, Issue 4, 2014, Pages 642-647

  Dimagno, Matthew J ^a,b,d   Wamsteker, Erik Jan ^a,b   Maratt, Jennifer ^a   Rivera, Mari A ^a   Spaete, Joshua P ^a   Ballard, Darren D ^a   Elmunzer, B Joseph ^a,b   Saini, Sameer D ^a,b,c  

^a Department of Internal Medicine ^*  (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Acute pancreatitis; Ercp; Fluid volumes; Severity

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANNULATION; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FLUID INTAKE; FLUID THERAPY; FLUID VOLUME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREATIC DUCT STENT; PANCREATITIS; POST ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SPHINCTEROTOMY; VATER PAPILLA STENOSIS; ACUTE DISEASE; CHI SQUARE DISTRIBUTION; MULTIVARIATE ANALYSIS; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; CHI-SQUARE DISTRIBUTION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; FLUID THERAPY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATITIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84898484248     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000101     Document Type: Article

References (44)

1. Elliott DW. Treatment of acute pancreatitis with albumin and whole blood. AMA Arch Surg. 1957;75:573-579.
2. Elliott DW, Zollinger RM, Moore R, et al. The use of human serum albumin in the management of acute pancreatitis; experimental and clinical observations. Gastroenterology. 1955;28:563-587.
3. Klar E, Messmer K, Warshaw AL, et al. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg. 1990;77:1205-1210.
4. DiMagno MJ, Williams JA, Hao Y, et al. Endothelial nitric oxide synthase is protective in the initiation of caerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2004;287:G80-G87.
5. Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg. 2006;93:518-530.
6. Gardner TB, Vege SS, Pearson RK, et al. Fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol. 2008;6:1070-1076.
7. DiMagno MJ, Wamsteker EJ, DeBenedet AT. Advances in managing acute pancreatitis. F1000 Med Rep. 2009;1:59.
8. Haydock MD, Mittal A, Wilms HR, et al. Fluid therapy in acute pancreatitis: anybody?s guess. Ann Surg. 2013;257:182-188.
9. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-1377.
10. DiMagno MJ, Spaete JP, Ballard DD, et al. Risk models for post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP). Smoking and chronic liver disease are predictors of protection against PEP. Pancreas. 2013;42:996-1003.
11. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425-434.
12. Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139-147.
13. Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy. 2007;39:793-801.
14. Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104:31-40.
15. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-393.
16. Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73:275-282.
17. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414-1422.
18. Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57:1262-1267.
19. Reddy N, Wilcox CM, Tamhane A, et al. Protocol-based medical management of post-ERCP pancreatitis. J Gastroenterol Hepatol. 2008;23:385-392.
20. DeBenedet AT, Raghunathan TE, Wing JJ, et al. Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009;7:353-358.
21. Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation. 1991;83:356-362.
22. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
23. Knol JA, Inman MG, Strodel WE, et al. Pancreatic response to crystalloid resuscitation in experimental pancreatitis. J Surg Res. 1987;43:387-392.
24. Horton JW, Burnweit CA. Hemodynamic function in acute pancreatitis. Surgery. 1988;103:538-546.
25. Niederau C, Crass RA, Silver G, et al. Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. Gastroenterology. 1988;95:1648-1657.
26. Trepte CJ, Bachmann KA, Stork JH, et al. The impact of early goal-directed fluid management on survival in an experimental model of severe acute pancreatitis. Intensive Care Med. 2013;39:717-726.
27. Shields CJ, Winter DC, Sookhai S, et al. Hypertonic saline attenuates end-organ damage in an experimental model of acute pancreatitis. Br J Surg. 2000;87:1336-1340.
28. Anderson MC, Lewis MB. Low-molecular-weight dextran therapy in experimental pancreatitis. JAMA.1965;192:398-400.
29. Donaldson LA,Williams RW, Schenk WG Jr. Experimental pancreatitis: effect of plasma and dextran on pancreatic blood flow. Surgery. 1978;84:313-321.
30. Donaldson LA, Schenk WG Jr. Experimental acute pancreatitis: the changes in pancreatic oxygen consumption and the effect of Dextran. Ann Surg. 1979;190:728-731.
31. Klar E, Herfarth C, Messmer K. Therapeutic effect of isovolemic hemodilution with dextran 60 on the impairment of pancreatic microcirculation in acute biliary pancreatitis. Ann Surg. 1990;211:346-353.
32. Schmidt J, Fernandez-del Castillo C, Rattner DW, et al. Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in rodent pancreatitis. Am J Surg. 1993;165:40-44.
33. Schmidt J, Huch K, Mithofer K, et al. Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat. Intensive Care Med. 1996;22:1207-1213.
34. Goodhead B. Acute pancreatitis and pancreatic blood flow. Surg Gynecol Obstet. 1969;129:331-340.
35. Knol JA, Edgcomb LP, Inman MG, et al. Low molecular weight dextran in experimental pancreatitis: effects on pancreatic microcirculation. J Surg Res. 1983;35:73-82.
36. Strate T, Mann O, Kleinhans H, et al. Microcirculatory function and tissue damage is improved after therapeutic injection of bovine hemoglobin in severe acute rodent pancreatitis. Pancreas. 2005;30:254-259.
37. Strate T, Mann O, Kleinhans H, et al. Systemic intravenous infusion of bovine hemoglobin significantly reduces microcirculatory dysfunction in experimentally induced pancreatitis in the rat. Ann Surg. 2003;238:765-771.
38. Leese T, West KP, Morton DB, et al. Fresh frozen plasma therapy in acute pancreatitis: an experimental study. Int J Pancreatol. 1988;3:437-447.
39. Wu BU, Hwang JQ, Gardner TH, et al. Lactated Ringer?s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9:710-717.
40. Du XJ, Hu WM, Xia Q, et al. Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis. Pancreas. 2011;40:1220-1225.
41. Leese T, Holliday M, Watkins M, et al. A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. Ann R Coll Surg Engl. 1991;73:207-214.
42. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-2256.
43. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer?s acetate in severe sepsis. N Engl J Med. 2012;367:124-134.
44. Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2007;5:1354Y1365.